CHMP recommends interim changes to prescriber advice for GSK's Pandemrix
18 April 2011
Mike Ward
Please Login to read the full article.
18 April 2011
Mike Ward
Please Login to read the full article.
RELATED CONTENT
NEWS
- CHMP opines positively on Dificlir, hypertension and diabetes combos, but restricts Multaq
- Janssen's Incivo to outshine Merck's Victrelis after fast-tracked NICE yes
- EU reprieve for Actos as CHMP concludes benefits outweigh risks in selected patients
- FDA warns about Actos link to bladder cancer, but no US ban yet
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
